Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT

被引：71
|
作者：
Redjoul, Rabah [1 ]
Le Bouter, Anne [2 ]
Parinet, Vincent [1 ]
Fourati, Slim [2 ,3 ]
Maury, Sebastien [1 ,2 ,3 ]
机构：
[1] Henri Mondor Hosp, AP HP, Dept Haematol, F-94000 Creteil, France
[2] Henri Mondor Hosp, AP HP, Dept Virol, F-94000 Creteil, France
[3] Univ Paris Est Creteil Val Marne, INSERM U955, Creteil, France
来源：
LANCET HAEMATOLOGY | 2021年 / 8卷 / 10期
关键词：
COVID-19; OUTCOMES;
D O I：
10.1016/S2352-3026(21)00274-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E681 / E683
页数：3
相关论文
共 50 条
  • [21] Antibody Response After a Fifth Dose (Third Booster) of BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers
    Saiag, Esther
    Gamzu, Ronni
    Padova, Hagit
    Paran, Yael
    Goldiner, Ilana
    Cohen, Neta
    Bomze, David
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (21)
  • [22] Humoral and cellular Immune Response after a Single Dose of BNT162b2
    Krome, Susanne
    TRANSFUSIONSMEDIZIN, 2021, 11 (04) : 217 - 218
  • [23] SARS-CoV-2 Antibody Response and Sustainability after a Third Dose of BNT162b2 in Healthcare Workers at Health Promotion Centers
    Nah, Eun-Hee
    Cho, Seon
    Park, Hyeran
    Kim, Suyoung
    Noh, Dongwon
    Kwon, Eunjoo
    Cho, Han-Ik
    VIRUSES-BASEL, 2023, 15 (03):
  • [24] T cell and antibody response following double dose of BNT162b2 mRNA Vaccine in heart transplant recipients
    Leen, Delrue
    Muylaert, A.
    Ann, Beernaert
    Imke, De Pelsmaecker
    Elly, Boel
    Ana, Moya
    Sofie, Verstreken
    Riet, Dierckx
    Ward, Heggermont
    Jozef, Bartunek
    Vanderheyden, M. Marc
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 99 - 99
  • [25] Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients
    Canti, Lorenzo
    Arien, Kevin K.
    Desombere, Isabelle
    Humblet-Baron, Stephanie
    Pannus, Pieter
    Heyndrickx, Leo
    Henry, Aurelie
    Servais, Sophie
    Willems, Evelyne
    Ehx, Gregory
    Goriely, Stanislas
    Seidel, Laurence
    Michiels, Johan
    Willems, Betty
    Goossens, Maria E.
    Beguin, Yves
    Marchant, Arnaud
    Baron, Frederic
    CANCER CELL, 2022, 40 (04) : 335 - 337
  • [26] Waning antibody response and cellular immunity 6 months after third dose SARS-Cov-2 mRNA BNT162b2 vaccine in kidney transplant recipients
    Bertrand, Dominique
    Lemee, Veronique
    Laurent, Charlotte
    Lemoine, Mathilde
    Hanoy, Melanie
    Le Roy, Frank
    Nezam, Dorian
    Pruteanu, Diana
    Lebourg, Ludivine
    Grange, Steven
    Plantier, Jean-Christophe
    Boyer, Olivier
    Guerrot, Dominique
    Candon, Sophie
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 (05) : 1498 - 1500
  • [27] Improved immunogenicity following the third dose of BNT162b2 mRNA vaccine in heart transplant recipients
    Shaul, Aviv Avraham
    Ben Zadok, Osnat Itzhaki
    Ben-Avraham, Binyamin
    Yaari, Vicky
    Barsheshet, Alon
    Levi, Amos
    Ben Zvi, Haim
    Raz, Noa Eliakim
    Abed, Galia
    Abuhazira, Miriam
    Abu Akel, Mahmood
    Mats, Israel
    Barac, Yaron D.
    Aravot, Dan
    Kornowski, Ran
    Ben-Gal, Tuvia
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2022, 62 (04)
  • [28] Antibody titres before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients with cancer
    Debie, Yana
    Vandamme, Timon
    Goossens, Maria E.
    van Dam, Peter A.
    Peeters, Marc
    EUROPEAN JOURNAL OF CANCER, 2022, 163 : 177 - 179
  • [29] Improved humoral immunogenicity with mRNA-1273 versus BNT162b2 as third vaccine dose among solid organ transplant recipients seronegative after two BNT162b2 doses
    Chang, Amy
    Chiang, Teresa PY.
    Kim, Jake D.
    Mitchell, Jonathan
    Alejo, Jennifer L.
    Jefferis, Alexa A.
    Avery, Robin K.
    Tobian, Aaron A. R.
    Levan, Macey L.
    Warren, Daniel S.
    Garonzik-Wang, Jacqueline M.
    Massie, Allan B.
    Segev, Dorry L.
    Werbel, William A.
    CLINICAL TRANSPLANTATION, 2022, 36 (08)
  • [30] Comparison of SARS-CoV-2 Antibody Levels after a Third Heterologous and Homologous BNT162b2 Booster Dose
    Gareayaghi, Nesrin
    Demirci, Mehmet
    Ozbey, Dogukan
    Dasdemir, Ferhat
    Dinc, Harika Oyku
    Balkan, Ilker Inanc
    Saribas, Suat
    Saltoglu, Nese
    Kocazeybek, Bekir
    VACCINES, 2022, 10 (10)
12345